231 related articles for article (PubMed ID: 22426576)
1. Electroretinographic (ERG) responses in pediatric patients using vigabatrin.
Moskowitz A; Hansen RM; Eklund SE; Fulton AB
Doc Ophthalmol; 2012 Jun; 124(3):197-209. PubMed ID: 22426576
[TBL] [Abstract][Full Text] [Related]
2. Changes in the ERG d-wave with vigabatrin treatment in a pediatric cohort.
Dragas R; Westall C; Wright T
Doc Ophthalmol; 2014 Oct; 129(2):97-104. PubMed ID: 25008578
[TBL] [Abstract][Full Text] [Related]
3. Vigabatrin effect on inner retinal function.
Coupland SG; Zackon DH; Leonard BC; Ross TM
Ophthalmology; 2001 Aug; 108(8):1493-6; discussion 1497-8. PubMed ID: 11470707
[TBL] [Abstract][Full Text] [Related]
4. Multifocal ERG and full-field ERG in patients on long-term vigabatrin medication.
Ponjavic V; Andréasson S
Doc Ophthalmol; 2001 Jan; 102(1):63-72. PubMed ID: 11475366
[TBL] [Abstract][Full Text] [Related]
5. Separating the retinal electrophysiologic effects of vigabatrin: treatment versus field loss.
Harding GF; Wild JM; Robertson KA; Rietbrock S; Martinez C
Neurology; 2000 Aug; 55(3):347-52. PubMed ID: 10932265
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of the retinal nerve fibre layer and reduced retinal function assessed by optical coherence tomography and full-field electroretinography in patients exposed to vigabatrin medication.
Kjellström U; Andréasson S; Ponjavic V
Acta Ophthalmol; 2014 Mar; 92(2):149-57. PubMed ID: 23387307
[TBL] [Abstract][Full Text] [Related]
7. Visual field and electrophysiological abnormalities due to vigabatrin.
van der Torren K; Graniewski-Wijnands HS; Polak BC
Doc Ophthalmol; 2002 Mar; 104(2):181-8. PubMed ID: 11999625
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological evaluation of retinal function in children receiving vigabatrin medication.
Kjellström U; Andréasson S; Ponjavic V
J Pediatr Ophthalmol Strabismus; 2011; 48(6):357-65. PubMed ID: 21261244
[TBL] [Abstract][Full Text] [Related]
9. Full-field ERG and visual fields in patients 5 years after discontinuing vigabatrin therapy.
Kjellström U; Lövestam-Adrian M; Andréasson S; Ponjavic V
Doc Ophthalmol; 2008 Sep; 117(2):93-101. PubMed ID: 18188629
[TBL] [Abstract][Full Text] [Related]
10. Rod and rod-driven function in achromatopsia and blue cone monochromatism.
Moskowitz A; Hansen RM; Akula JD; Eklund SE; Fulton AB
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):950-8. PubMed ID: 18824728
[TBL] [Abstract][Full Text] [Related]
11. Binasal visual field defects are not specific to vigabatrin.
Gonzalez P; Sills GJ; Parks S; Kelly K; Stephen LJ; Keating D; Dutton GN; Brodie MJ
Epilepsy Behav; 2009 Nov; 16(3):521-6. PubMed ID: 19815465
[TBL] [Abstract][Full Text] [Related]
12. Retinal function abnormalities in patients treated with vigabatrin.
Banin E; Shalev RS; Obolensky A; Neis R; Chowers I; Gross-Tsur V
Arch Ophthalmol; 2003 Jun; 121(6):811-6. PubMed ID: 12796251
[TBL] [Abstract][Full Text] [Related]
13. Examining visual field defects in the paediatric population exposed to vigabatrin.
Spencer EL; Harding GF
Doc Ophthalmol; 2003 Nov; 107(3):281-7. PubMed ID: 14711160
[TBL] [Abstract][Full Text] [Related]
14. Vigabatrin retinal toxicity in children with infantile spasms: An observational cohort study.
Westall CA; Wright T; Cortese F; Kumarappah A; Snead OC; Buncic JR
Neurology; 2014 Dec; 83(24):2262-8. PubMed ID: 25381295
[TBL] [Abstract][Full Text] [Related]
15. Field-specific visual-evoked potentials: identifying field defects in vigabatrin-treated children.
Harding GF; Spencer EL; Wild JM; Conway M; Bohn RL
Neurology; 2002 Apr; 58(8):1261-5. PubMed ID: 11971096
[TBL] [Abstract][Full Text] [Related]
16. Vigabatrin: longterm follow-up of electrophysiology and visual field examinations.
Hardus P; Verduin W; Berendschot T; Postma G; Stilma J; van Veelen C
Acta Ophthalmol Scand; 2003 Oct; 81(5):459-65. PubMed ID: 14510792
[TBL] [Abstract][Full Text] [Related]
17. Vigabatrin can enhance electroretinographic responses in pigmented and albino rats.
Akula JD; Noonan ER; Di Nardo A; Favazza TL; Zhang N; Sahin M; Hansen RM; Fulton AB
Doc Ophthalmol; 2015 Aug; 131(1):1-11. PubMed ID: 25761928
[TBL] [Abstract][Full Text] [Related]
18. Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings.
Krauss GL; Johnson MA; Miller NR
Neurology; 1998 Mar; 50(3):614-8. PubMed ID: 9521245
[TBL] [Abstract][Full Text] [Related]
19. Vigabatrin and retinal changes.
Jensen H; Sjö O; Uldall P; Gram L
Doc Ophthalmol; 2002 Mar; 104(2):171-80. PubMed ID: 11999624
[TBL] [Abstract][Full Text] [Related]
20. Photoreceptor and postreceptor responses in congenital stationary night blindness.
Raghuram A; Hansen RM; Moskowitz A; Fulton AB
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4648-58. PubMed ID: 23761088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
